- Home
- KINS vs BIOA Comparison
KINS vs BIOA Comparison
Compare KINS & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KINS
- BIOA
- Stock Information
- Founded
- KINS 1886
- BIOA 2015
- Country
- KINS United States
- BIOA United States
- Employees
- KINS N/A
- BIOA N/A
- Industry
- KINS Property-Casualty Insurers
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- KINS Finance
- BIOA Health Care
- Exchange
- KINS Nasdaq
- BIOA Nasdaq
- Market Cap
- KINS 189.6M
- BIOA 175.7M
- IPO Year
- KINS N/A
- BIOA 2024
- Fundamental
- Price
- KINS $13.73
- BIOA $5.22
- Analyst Decision
- KINS
- BIOA Hold
- Analyst Count
- KINS 0
- BIOA 4
- Target Price
- KINS N/A
- BIOA $5.67
- AVG Volume (30 Days)
- KINS 149.6K
- BIOA 190.2K
- Earning Date
- KINS 10-28-2025
- BIOA 11-06-2025
- Dividend Yield
- KINS 1.46%
- BIOA N/A
- EPS Growth
- KINS 325.10
- BIOA N/A
- EPS
- KINS 2.04
- BIOA N/A
- Revenue
- KINS $183,702,376.00
- BIOA $3,863,000.00
- Revenue This Year
- KINS $41.35
- BIOA N/A
- Revenue Next Year
- KINS $12.33
- BIOA N/A
- P/E Ratio
- KINS $6.70
- BIOA N/A
- Revenue Growth
- KINS 28.36
- BIOA N/A
- 52 Week Low
- KINS $8.36
- BIOA $2.88
- 52 Week High
- KINS $22.40
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- KINS 46.67
- BIOA 65.41
- Support Level
- KINS $13.38
- BIOA $4.68
- Resistance Level
- KINS $13.92
- BIOA $5.09
- Average True Range (ATR)
- KINS 0.47
- BIOA 0.25
- MACD
- KINS 0.08
- BIOA 0.02
- Stochastic Oscillator
- KINS 43.28
- BIOA 91.78
About KINS Kingstone Companies Inc.
Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.